News

Christopher Schaber, president and CEO of Dor BioPharma, said: “We are pleased with the Therapeutics Goods Administration’s decision to grant orBec orphan drug designation for the treatment of

Upon completion of the transaction, RA Group Holdings (RAGH), through its operating companies, will serve approximately 10,500 patients in 136 dialysis centers in 18 states. Laboratory services to

Under the terms of the agreement Dako and Genentech will collaborate on developing a new cancer diagnostic test as a potential companion product for a specific Genentech investigational

Evaluation of new subjects continues at the trial’s active centers in Adelaide, Brisbane and Sydney, Australia, as well as at MD Anderson, St Luke’s and the California Pacific

Ms Brainerd is the president and CEO of HealthPartners, a family of non-profit Minnesota health care organizations. She also serves on the boards of Minnesota Life/Securian, The St

This collaboration is expected to support the development and commercial offering of 14 products over a two-year span, with a planned launch of many of these products in

Teva has previously launched its generic budesonide respules in the US. The agreement releases Teva for all past US sales of its generic budesonide respules and provides that

Chattem is registered with the US Drug Enforcement Administration (DEA) as a narcotic raw material importer. This import registration includes four controlled substance products listed in Schedule 2:

Mr Singer is CEO of The BrainScope Company, a privately held neurotechnology company. Mr Singer has held executive level positions at Revolution, where he was instrumental in the